• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Vicarious Surgical Inc.

    2/17/22 4:52:03 PM ET
    $RBOT
    Industrial Specialties
    Health Care
    Get the next $RBOT alert in real time by email
    SC 13G 1 d311670dsc13g.htm SC 13G SC 13G

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.     )*

     

     

    Vicarious Surgical Inc.

    (Name of Issuer)

    Class A common stock

    (Title of Class of Securities)

    92561V109

    (CUSIP Number)

    February 7, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 92561V109   Schedule 13G    Page 1 of 7

     

      1    

      Names of Reporting Persons

     

      Sun Hung Kai & Co. Ltd.

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Hong Kong

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      0

       6  

      Shared Voting Power

     

      5,148,970

       7  

      Sole Dispositive Power

     

      0

       8  

      Shared Dispositive Power

     

      5,148,970

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,148,970

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      5.2%

    12  

      Type of Reporting Person

     

      CO


    CUSIP No. 92561V109   Schedule 13G    Page 2 of 7

     

      1    

      Names of Reporting Persons

     

      Shipshape Investments Ltd.

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      British Virgin Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      0

       6  

      Shared Voting Power

     

      5,148,970

       7  

      Sole Dispositive Power

     

      0

       8  

      Shared Dispositive Power

     

      5,148,970

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,148,970

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      5.2%

    12  

      Type of Reporting Person

     

      CO


    CUSIP No. 92561V109   Schedule 13G    Page 3 of 7

     

      1    

      Names of Reporting Persons

     

      Sun Hung Kai Strategic Capital Ltd.

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Hong Kong

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      0

       6  

      Shared Voting Power

     

      5,148,970

       7  

      Sole Dispositive Power

     

      0

       8  

      Shared Dispositive Power

     

      5,148,970

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,148,970

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      5.2%

    12  

      Type of Reporting Person

     

      CO


    CUSIP No. 92561V109   Schedule 13G    Page 4 of 7

     

    ITEM 1.

    (a) Name of Issuer:

    Vicarious Surgical Inc. (the “Issuer”)

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    78 Fourth Avenue, Waltham, Massachusetts 02451

     

    ITEM 2.

    (a) Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    Sun Hung Kai & Co. Ltd.

    Shipshape Investments Ltd.

    Sun Hung Kai Strategic Capital Ltd.

     

      (b)

    Address or Principal Business Office:

    The address of each of the Reporting Persons is 42/F Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

     

      (c)

    Citizenship of each Reporting Person is:

    Shipshape Investments Ltd. is organized under the laws of the British Virgin Islands. Each of the other Reporting Persons is organized under the laws of Hong Kong.

     

      (d)

    Title of Class of Securities:

    Class A common stock, par value $0.0001 per share (“Class A Common Stock”).

     

      (e)

    CUSIP Number:

    92561V109

     

    ITEM 3.

    Not applicable.


    CUSIP No. 92561V109   Schedule 13G    Page 5 of 7

     

    ITEM 4.

    Ownership.

    (a-c)

    The ownership information presented below represents beneficial ownership of Class A Common Stock of the Issuer as of February 7, 2022, based upon 98,832,452 shares of Common Stock outstanding as of November 1, 2021, as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2021.

     

    Reporting Person   

    Amount

    beneficially

    owned

        

    Percent

    of class:

        Sole power
    to vote or to
    direct the
    vote:
         Shared
    power to
    vote or to
    direct the
    vote:
        

    Sole power to
    dispose or to
    direct the
    disposition

    of:

        

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     

    Sun Hung Kai & Co. Ltd.

         5,148,970        5.2 %      0        5,148,970        0        5,148,970  

    Shipshape Investments Ltd.

         5,148,970        5.2 %      0        5,148,970        0        5,148,970  

    Sun Hung Kai Strategic Capital Ltd.

         5,148,970        5.2 %      0        5,148,970        0        5,148,970  

    Sun Hung Kai Strategic Capital Ltd. is the record holder of the securities reported herein. Sun Hung Kai & Co. Ltd., a publicly traded company listed on the Stock Exchange of Hong Kong, is the sole shareholder of Shipshape Investments Ltd., which is the sole shareholder of Sun Hung Kai Strategic Capital Ltd. As a result of these relationships, each of the Reporting Persons may be deemed to share beneficial ownership of the securities reported herein.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 92561V109   Schedule 13G    Page 6 of 7

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:    February 17, 2022

     

    Sun Hung Kai & Co. Ltd.

    /s/ Lee Sze Wai

    By:   Lee Sze Wai
    Title:   Company Secretary
    Shipshape Investments Ltd.

    /s/ Lee Sze Wai

    By:   Lee Sze Wai
    Title:   Company Secretary
    Sun Hung Kai Strategic Capital Ltd.

    /s/ Lee Sze Wai

    By:   Lee Sze Wai
    Title:   Company Secretary


    CUSIP No. 92561V109   Schedule 13G    Page 7 of 7

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    99    Joint Filing Agreement.
    Get the next $RBOT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RBOT

    DatePrice TargetRatingAnalyst
    3/4/2022$16.00 → $7.00Overweight → Neutral
    Piper Sandler
    1/7/2022$16.00Outperform
    Credit Suisse
    12/7/2021$15.00Outperform
    Cowen & Co.
    11/5/2021$15.00Buy
    Canaccord Genuity
    10/18/2021$15.00Buy
    BTIG
    10/7/2021$16.00Overweight
    Piper Sandler
    More analyst ratings

    $RBOT
    Leadership Updates

    Live Leadership Updates

    See more
    • Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

      Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer (CFO), effective April 1, 2025. Ms. Romano will oversee Vicarious Surgical's financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic acumen, Ms. Romano has a proven record of driving growth and value creation in public companies, particularly in the h

      3/13/25 8:30:00 AM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0 System ("V1.0"), the newly established role of President is designed to fortify organizational alignment and focus on the Company's long-term needs and objectives. Reporting to Chief Executive Officer Adam Sachs, Mr. Clark will a

      1/29/24 8:30:00 AM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Vicarious Surgical Announces Changes to Board of Directors

      Victoria Carr-Brendel, Ph.D. Elected to Board of Directors Tech-Focused Venture Capitalist Phil Liang to Resign Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors effective as of today. "On behalf of the board, I'd like to thank Phil for his critical guidance and expertise as Vicari

      1/23/23 4:10:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Khalifa Sammy sold $1,733 worth of shares (239 units at $7.25), decreasing direct ownership by 0.67% to 35,630 units (SEC Form 4)

      4 - Vicarious Surgical Inc. (0001812173) (Issuer)

      6/4/25 2:16:21 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • CEO Sachs Adam David sold $3,343 worth of shares (463 units at $7.22), decreasing direct ownership by 0.90% to 50,723 units (SEC Form 4)

      4 - Vicarious Surgical Inc. (0001812173) (Issuer)

      6/4/25 2:16:05 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Chief Technology Officer Khalifa Sammy sold $4,912 worth of shares (653 units at $7.52), decreasing direct ownership by 2% to 35,869 units (SEC Form 4)

      4 - Vicarious Surgical Inc. (0001812173) (Issuer)

      5/21/25 1:19:38 PM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Vicarious Surgical downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Vicarious Surgical from Overweight to Neutral and set a new price target of $7.00 from $16.00 previously

      3/4/22 4:51:18 AM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Credit Suisse initiated coverage on Vicarious Surgical with a new price target

      Credit Suisse initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $16.00

      1/7/22 7:09:02 AM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Cowen & Co. initiated coverage on Vicarious Surgical with a new price target

      Cowen & Co. initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $15.00

      12/7/21 7:31:51 AM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    Financials

    Live finance-specific insights

    See more
    • Vicarious Surgical Reports First Quarter 2025 Financial Results

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. "Following years of meticulous work to develop and advance our surgical system and proprietary decoupled actuating technology, we are just a few quarters away from our biggest milestone yet - our first clinical patients. 2025 will be the year Vicarious Surgical evolves into a clinical-stage company and demonstrates the immense value of o

      5/12/25 4:05:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the first quarter ended March 31, 2025 after the market closes on Monday, May 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 316641. A live and archived webcast of the event will be available at https://investor.v

      4/28/25 4:05:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results

      Version 1.0 System Integration Complete; Progressing Towards First Clinical Use Achieved 2024 Cash Burn Guidance; Sets 2025 Cash Burn Guidance of $50 Million Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter and full year ended December 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, March 17, 2025. "2024 was a pivotal year of progress for Vicarious Surgical, as we expanded our strategic hospital partnerships with LSU Health New Orleans, Temple Health, and Univers

      3/17/25 4:05:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

      RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (NASDAQ:GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Victoria E. Carr-Brendel, PhD, was elected to the Company's Board of Directors, effective May 22, 2025. "We are delighted to welcome Dr. Carr-Brendel to Glucotrack's Board of Directors," said Paul V. Goode, PhD, President and Chief Executive Officer of Glucotrack. "With her exceptional leadership in medical devices and deep expertise in implantable technologies, she will be an invaluable addition to the Board as we advance our continuous blood glucose monito

      5/28/25 8:30:00 AM ET
      $GCTK
      $RBOT
      Medical/Dental Instruments
      Health Care
      Industrial Specialties
    • Vicarious Surgical Reports First Quarter 2025 Financial Results

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. "Following years of meticulous work to develop and advance our surgical system and proprietary decoupled actuating technology, we are just a few quarters away from our biggest milestone yet - our first clinical patients. 2025 will be the year Vicarious Surgical evolves into a clinical-stage company and demonstrates the immense value of o

      5/12/25 4:05:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center

      Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed an agreement with UMass Memorial Medical Center intended to support adoption and utilization of its robotic system through enhanced perioperative practices, surgeon education and other engagement strategies. UMass Memorial Medical Center, the flagship academic medical center of UMass Memorial Health, is the largest not-for-profit hospital in Central Massachusetts with 826 licensed beds and the clinical partner of the University of Massachusetts Chan Medical School. UMass Memorial Health is committed to prov

      5/12/25 4:05:00 PM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    SEC Filings

    See more
    • Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Vicarious Surgical Inc. (0001812173) (Filer)

      5/12/25 7:47:13 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • SEC Form 10-Q filed by Vicarious Surgical Inc.

      10-Q - Vicarious Surgical Inc. (0001812173) (Filer)

      5/12/25 5:00:42 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • SEC Form 144 filed by Vicarious Surgical Inc.

      144 - Vicarious Surgical Inc. (0001812173) (Subject)

      5/1/25 4:48:24 PM ET
      $RBOT
      Industrial Specialties
      Health Care

    $RBOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

      SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

      2/13/24 4:36:42 PM ET
      $RBOT
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

      SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

      8/15/23 10:28:36 AM ET
      $RBOT
      Industrial Specialties
      Health Care
    • SEC Form SC 13D/A filed by Vicarious Surgical Inc. (Amendment)

      SC 13D/A - Vicarious Surgical Inc. (0001812173) (Subject)

      8/9/23 5:10:57 PM ET
      $RBOT
      Industrial Specialties
      Health Care